Targeting immunosenescence post cancer by boosting metabolic health

Research unit

INNOSUISSE

Project number

62799.1 IP-LS

Project title

Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)
Short description (English)	Targeting immunosenescence post cancer by boosting metabolic health
Abstract (German)	Amazentis has discovered a novel nutrient that improves immune function by boosting mitochondrial health. These findings are applicable for cancer survivors with a weak immune system. A study with leading oncologists at CHUV is proposed to translate and commercialize an advanced nutrition product.